nodes	percent_of_prediction	percent_of_DWPC	metapath
Mefenamic acid—AKR1C3—stomach cancer	0.477	0.851	CbGaD
Mefenamic acid—AKR1C3—Doxorubicin—stomach cancer	0.157	0.715	CbGbCtD
Mefenamic acid—PTGS2—stomach cancer	0.0836	0.149	CbGaD
Mefenamic acid—CYP2C9—Capecitabine—stomach cancer	0.0257	0.117	CbGbCtD
Mefenamic acid—CYP2C8—Fluorouracil—stomach cancer	0.0218	0.0993	CbGbCtD
Mefenamic acid—CYP2C9—Fluorouracil—stomach cancer	0.0152	0.0692	CbGbCtD
Mefenamic acid—AKR1C2—liver—stomach cancer	0.00193	0.118	CbGeAlD
Mefenamic acid—AKR1C2—lymph node—stomach cancer	0.00148	0.0905	CbGeAlD
Mefenamic acid—AKR1C3—smooth muscle tissue—stomach cancer	0.00102	0.0626	CbGeAlD
Mefenamic acid—AKR1C3—pancreas—stomach cancer	0.000944	0.0579	CbGeAlD
Mefenamic acid—PTGS1—blood vessel—stomach cancer	0.000771	0.0472	CbGeAlD
Mefenamic acid—AKR1C3—bone marrow—stomach cancer	0.000744	0.0456	CbGeAlD
Mefenamic acid—PTGS2—blood vessel—stomach cancer	0.000737	0.0451	CbGeAlD
Mefenamic acid—Meclofenamic acid—AKR1C3—stomach cancer	0.000725	0.159	CrCbGaD
Mefenamic acid—PTGS2—gall bladder—stomach cancer	0.000693	0.0425	CbGeAlD
Mefenamic acid—AKR1C3—liver—stomach cancer	0.000601	0.0368	CbGeAlD
Mefenamic acid—Meclofenamic acid—ALOX5—stomach cancer	0.000526	0.116	CrCbGaD
Mefenamic acid—CYP2C8—hematopoietic system—stomach cancer	0.000506	0.031	CbGeAlD
Mefenamic acid—Acetylsalicylic acid—TP53—stomach cancer	0.000493	0.108	CrCbGaD
Mefenamic acid—AKR1C3—lymph node—stomach cancer	0.000461	0.0282	CbGeAlD
Mefenamic acid—CYP2C9—hematopoietic system—stomach cancer	0.00045	0.0275	CbGeAlD
Mefenamic acid—PTGS1—hematopoietic system—stomach cancer	0.00041	0.0251	CbGeAlD
Mefenamic acid—PTGS2—hematopoietic system—stomach cancer	0.000392	0.024	CbGeAlD
Mefenamic acid—PTGS1—epithelium—stomach cancer	0.000375	0.023	CbGeAlD
Mefenamic acid—PTGS1—smooth muscle tissue—stomach cancer	0.000361	0.0222	CbGeAlD
Mefenamic acid—PTGS2—epithelium—stomach cancer	0.000359	0.022	CbGeAlD
Mefenamic acid—PTGS2—smooth muscle tissue—stomach cancer	0.000345	0.0212	CbGeAlD
Mefenamic acid—PTGS2—pancreas—stomach cancer	0.000319	0.0196	CbGeAlD
Mefenamic acid—CYP2C9—digestive system—stomach cancer	0.000313	0.0192	CbGeAlD
Mefenamic acid—Diclofenac—ALOX5—stomach cancer	0.000294	0.0646	CrCbGaD
Mefenamic acid—CYP2C8—endocrine gland—stomach cancer	0.000291	0.0178	CbGeAlD
Mefenamic acid—PTGS1—digestive system—stomach cancer	0.000285	0.0175	CbGeAlD
Mefenamic acid—PTGS2—lymphoid tissue—stomach cancer	0.000276	0.0169	CbGeAlD
Mefenamic acid—PTGS2—digestive system—stomach cancer	0.000273	0.0167	CbGeAlD
Mefenamic acid—CYP2C8—liver—stomach cancer	0.000262	0.0161	CbGeAlD
Mefenamic acid—CYP2C9—endocrine gland—stomach cancer	0.000258	0.0158	CbGeAlD
Mefenamic acid—Floctafenine—PTGS2—stomach cancer	0.000253	0.0556	CrCbGaD
Mefenamic acid—PTGS2—bone marrow—stomach cancer	0.000251	0.0154	CbGeAlD
Mefenamic acid—Diclofenac—CXCL8—stomach cancer	0.000244	0.0535	CrCbGaD
Mefenamic acid—PTGS1—endocrine gland—stomach cancer	0.000236	0.0145	CbGeAlD
Mefenamic acid—CYP2C9—liver—stomach cancer	0.000233	0.0143	CbGeAlD
Mefenamic acid—PTGS2—endocrine gland—stomach cancer	0.000225	0.0138	CbGeAlD
Mefenamic acid—Ketoprofen—CXCL8—stomach cancer	0.000216	0.0474	CrCbGaD
Mefenamic acid—PTGS2—liver—stomach cancer	0.000203	0.0125	CbGeAlD
Mefenamic acid—Lumiracoxib—PTGS2—stomach cancer	0.000163	0.0358	CrCbGaD
Mefenamic acid—Tiaprofenic acid—PTGS2—stomach cancer	0.000163	0.0358	CrCbGaD
Mefenamic acid—PTGS1—lymph node—stomach cancer	0.000163	0.00999	CbGeAlD
Mefenamic acid—PTGS2—lymph node—stomach cancer	0.000156	0.00955	CbGeAlD
Mefenamic acid—Nepafenac—PTGS2—stomach cancer	0.000155	0.0341	CrCbGaD
Mefenamic acid—Niflumic Acid—PTGS2—stomach cancer	0.000145	0.0319	CrCbGaD
Mefenamic acid—Salsalate—PTGS2—stomach cancer	0.000129	0.0283	CrCbGaD
Mefenamic acid—Meclofenamic acid—PTGS2—stomach cancer	0.000127	0.0279	CrCbGaD
Mefenamic acid—Fenoprofen—PTGS2—stomach cancer	0.000107	0.0234	CrCbGaD
Mefenamic acid—Anaphylactic shock—Docetaxel—stomach cancer	0.000105	0.00089	CcSEcCtD
Mefenamic acid—Oedema—Docetaxel—stomach cancer	0.000105	0.00089	CcSEcCtD
Mefenamic acid—Discomfort—Capecitabine—stomach cancer	0.000105	0.000888	CcSEcCtD
Mefenamic acid—Urethral disorder—Methotrexate—stomach cancer	0.000104	0.000885	CcSEcCtD
Mefenamic acid—Infection—Docetaxel—stomach cancer	0.000104	0.000884	CcSEcCtD
Mefenamic acid—Hyperglycaemia—Doxorubicin—stomach cancer	0.000104	0.000881	CcSEcCtD
Mefenamic acid—Diarrhoea—Irinotecan—stomach cancer	0.000104	0.000881	CcSEcCtD
Mefenamic acid—Dry mouth—Capecitabine—stomach cancer	0.000104	0.000879	CcSEcCtD
Mefenamic acid—Agranulocytosis—Epirubicin—stomach cancer	0.000104	0.000879	CcSEcCtD
Mefenamic acid—Pneumonia—Doxorubicin—stomach cancer	0.000103	0.000876	CcSEcCtD
Mefenamic acid—Shock—Docetaxel—stomach cancer	0.000103	0.000876	CcSEcCtD
Mefenamic acid—Pruritus—Fluorouracil—stomach cancer	0.000103	0.000873	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Docetaxel—stomach cancer	0.000103	0.000872	CcSEcCtD
Mefenamic acid—Drowsiness—Doxorubicin—stomach cancer	0.000103	0.000871	CcSEcCtD
Mefenamic acid—Confusional state—Capecitabine—stomach cancer	0.000103	0.000869	CcSEcCtD
Mefenamic acid—Tachycardia—Docetaxel—stomach cancer	0.000103	0.000869	CcSEcCtD
Mefenamic acid—Skin disorder—Docetaxel—stomach cancer	0.000102	0.000865	CcSEcCtD
Mefenamic acid—Stevens-Johnson syndrome—Doxorubicin—stomach cancer	0.000102	0.000864	CcSEcCtD
Mefenamic acid—Oedema—Capecitabine—stomach cancer	0.000102	0.000862	CcSEcCtD
Mefenamic acid—Renal failure—Doxorubicin—stomach cancer	0.000101	0.000856	CcSEcCtD
Mefenamic acid—Infection—Capecitabine—stomach cancer	0.000101	0.000856	CcSEcCtD
Mefenamic acid—Erythema multiforme—Methotrexate—stomach cancer	0.000101	0.000854	CcSEcCtD
Mefenamic acid—Dizziness—Irinotecan—stomach cancer	0.000101	0.000852	CcSEcCtD
Mefenamic acid—Haemoglobin—Epirubicin—stomach cancer	0.0001	0.000849	CcSEcCtD
Mefenamic acid—Stomatitis—Doxorubicin—stomach cancer	0.0001	0.000849	CcSEcCtD
Mefenamic acid—Jaundice—Doxorubicin—stomach cancer	0.0001	0.000849	CcSEcCtD
Mefenamic acid—Anorexia—Docetaxel—stomach cancer	0.0001	0.000849	CcSEcCtD
Mefenamic acid—Shock—Capecitabine—stomach cancer	0.0001	0.000848	CcSEcCtD
Mefenamic acid—Conjunctivitis—Doxorubicin—stomach cancer	9.99e-05	0.000847	CcSEcCtD
Mefenamic acid—Haemorrhage—Epirubicin—stomach cancer	9.98e-05	0.000845	CcSEcCtD
Mefenamic acid—Hepatitis—Epirubicin—stomach cancer	9.98e-05	0.000845	CcSEcCtD
Mefenamic acid—Diarrhoea—Fluorouracil—stomach cancer	9.96e-05	0.000844	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Capecitabine—stomach cancer	9.96e-05	0.000844	CcSEcCtD
Mefenamic acid—Tinnitus—Methotrexate—stomach cancer	9.94e-05	0.000842	CcSEcCtD
Mefenamic acid—Tachycardia—Capecitabine—stomach cancer	9.93e-05	0.000841	CcSEcCtD
Mefenamic acid—Skin disorder—Capecitabine—stomach cancer	9.88e-05	0.000837	CcSEcCtD
Mefenamic acid—Urinary tract disorder—Epirubicin—stomach cancer	9.85e-05	0.000835	CcSEcCtD
Mefenamic acid—Hypotension—Docetaxel—stomach cancer	9.82e-05	0.000832	CcSEcCtD
Mefenamic acid—Haematuria—Doxorubicin—stomach cancer	9.8e-05	0.000831	CcSEcCtD
Mefenamic acid—Urethral disorder—Epirubicin—stomach cancer	9.78e-05	0.000828	CcSEcCtD
Mefenamic acid—Anorexia—Capecitabine—stomach cancer	9.7e-05	0.000822	CcSEcCtD
Mefenamic acid—Vomiting—Irinotecan—stomach cancer	9.66e-05	0.000819	CcSEcCtD
Mefenamic acid—Acetylsalicylic acid—PTGS2—stomach cancer	9.63e-05	0.0212	CrCbGaD
Mefenamic acid—Dizziness—Fluorouracil—stomach cancer	9.63e-05	0.000816	CcSEcCtD
Mefenamic acid—Agranulocytosis—Doxorubicin—stomach cancer	9.59e-05	0.000813	CcSEcCtD
Mefenamic acid—Rash—Irinotecan—stomach cancer	9.58e-05	0.000812	CcSEcCtD
Mefenamic acid—Dermatitis—Irinotecan—stomach cancer	9.57e-05	0.000811	CcSEcCtD
Mefenamic acid—Headache—Irinotecan—stomach cancer	9.52e-05	0.000807	CcSEcCtD
Mefenamic acid—Hypotension—Capecitabine—stomach cancer	9.51e-05	0.000805	CcSEcCtD
Mefenamic acid—Insomnia—Docetaxel—stomach cancer	9.5e-05	0.000805	CcSEcCtD
Mefenamic acid—Fenoprofen—ALB—stomach cancer	9.5e-05	0.0209	CrCbGaD
Mefenamic acid—Paraesthesia—Docetaxel—stomach cancer	9.43e-05	0.000799	CcSEcCtD
Mefenamic acid—Erythema multiforme—Epirubicin—stomach cancer	9.43e-05	0.000799	CcSEcCtD
Mefenamic acid—Alopecia—Methotrexate—stomach cancer	9.42e-05	0.000798	CcSEcCtD
Mefenamic acid—Dyspnoea—Docetaxel—stomach cancer	9.37e-05	0.000794	CcSEcCtD
Mefenamic acid—Somnolence—Docetaxel—stomach cancer	9.34e-05	0.000791	CcSEcCtD
Mefenamic acid—Mental disorder—Methotrexate—stomach cancer	9.34e-05	0.000791	CcSEcCtD
Mefenamic acid—Tinnitus—Epirubicin—stomach cancer	9.3e-05	0.000788	CcSEcCtD
Mefenamic acid—Haemoglobin—Doxorubicin—stomach cancer	9.28e-05	0.000786	CcSEcCtD
Mefenamic acid—Vomiting—Fluorouracil—stomach cancer	9.26e-05	0.000784	CcSEcCtD
Mefenamic acid—Dyspepsia—Docetaxel—stomach cancer	9.25e-05	0.000784	CcSEcCtD
Mefenamic acid—Haemorrhage—Doxorubicin—stomach cancer	9.23e-05	0.000782	CcSEcCtD
Mefenamic acid—Hepatitis—Doxorubicin—stomach cancer	9.23e-05	0.000782	CcSEcCtD
Mefenamic acid—Insomnia—Capecitabine—stomach cancer	9.2e-05	0.00078	CcSEcCtD
Mefenamic acid—Rash—Fluorouracil—stomach cancer	9.18e-05	0.000778	CcSEcCtD
Mefenamic acid—Dermatitis—Fluorouracil—stomach cancer	9.17e-05	0.000777	CcSEcCtD
Mefenamic acid—Paraesthesia—Capecitabine—stomach cancer	9.13e-05	0.000774	CcSEcCtD
Mefenamic acid—Decreased appetite—Docetaxel—stomach cancer	9.13e-05	0.000774	CcSEcCtD
Mefenamic acid—Headache—Fluorouracil—stomach cancer	9.12e-05	0.000773	CcSEcCtD
Mefenamic acid—Urinary tract disorder—Doxorubicin—stomach cancer	9.11e-05	0.000772	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Docetaxel—stomach cancer	9.07e-05	0.000769	CcSEcCtD
Mefenamic acid—Dyspnoea—Capecitabine—stomach cancer	9.07e-05	0.000768	CcSEcCtD
Mefenamic acid—Urethral disorder—Doxorubicin—stomach cancer	9.05e-05	0.000767	CcSEcCtD
Mefenamic acid—Nausea—Irinotecan—stomach cancer	9.03e-05	0.000765	CcSEcCtD
Mefenamic acid—Constipation—Docetaxel—stomach cancer	8.98e-05	0.000761	CcSEcCtD
Mefenamic acid—Dyspepsia—Capecitabine—stomach cancer	8.95e-05	0.000759	CcSEcCtD
Mefenamic acid—Arrhythmia—Epirubicin—stomach cancer	8.91e-05	0.000755	CcSEcCtD
Mefenamic acid—Decreased appetite—Capecitabine—stomach cancer	8.84e-05	0.000749	CcSEcCtD
Mefenamic acid—Alopecia—Epirubicin—stomach cancer	8.81e-05	0.000747	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Capecitabine—stomach cancer	8.78e-05	0.000744	CcSEcCtD
Mefenamic acid—Vision blurred—Methotrexate—stomach cancer	8.74e-05	0.000741	CcSEcCtD
Mefenamic acid—Mental disorder—Epirubicin—stomach cancer	8.74e-05	0.00074	CcSEcCtD
Mefenamic acid—Erythema multiforme—Doxorubicin—stomach cancer	8.73e-05	0.000739	CcSEcCtD
Mefenamic acid—Constipation—Capecitabine—stomach cancer	8.7e-05	0.000737	CcSEcCtD
Mefenamic acid—Feeling abnormal—Docetaxel—stomach cancer	8.66e-05	0.000734	CcSEcCtD
Mefenamic acid—Nausea—Fluorouracil—stomach cancer	8.65e-05	0.000733	CcSEcCtD
Mefenamic acid—Ill-defined disorder—Methotrexate—stomach cancer	8.61e-05	0.000729	CcSEcCtD
Mefenamic acid—Tinnitus—Doxorubicin—stomach cancer	8.61e-05	0.000729	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Docetaxel—stomach cancer	8.59e-05	0.000728	CcSEcCtD
Mefenamic acid—Acetylsalicylic acid—ALB—stomach cancer	8.58e-05	0.0189	CrCbGaD
Mefenamic acid—Anaemia—Methotrexate—stomach cancer	8.58e-05	0.000727	CcSEcCtD
Mefenamic acid—Flatulence—Epirubicin—stomach cancer	8.56e-05	0.000725	CcSEcCtD
Mefenamic acid—Tension—Epirubicin—stomach cancer	8.52e-05	0.000722	CcSEcCtD
Mefenamic acid—Nervousness—Epirubicin—stomach cancer	8.43e-05	0.000715	CcSEcCtD
Mefenamic acid—Feeling abnormal—Capecitabine—stomach cancer	8.38e-05	0.00071	CcSEcCtD
Mefenamic acid—Malaise—Methotrexate—stomach cancer	8.37e-05	0.000709	CcSEcCtD
Mefenamic acid—Vertigo—Methotrexate—stomach cancer	8.34e-05	0.000706	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Capecitabine—stomach cancer	8.32e-05	0.000705	CcSEcCtD
Mefenamic acid—Body temperature increased—Docetaxel—stomach cancer	8.31e-05	0.000704	CcSEcCtD
Mefenamic acid—Abdominal pain—Docetaxel—stomach cancer	8.31e-05	0.000704	CcSEcCtD
Mefenamic acid—Leukopenia—Methotrexate—stomach cancer	8.31e-05	0.000704	CcSEcCtD
Mefenamic acid—Arrhythmia—Doxorubicin—stomach cancer	8.25e-05	0.000699	CcSEcCtD
Mefenamic acid—Vision blurred—Epirubicin—stomach cancer	8.18e-05	0.000693	CcSEcCtD
Mefenamic acid—Alopecia—Doxorubicin—stomach cancer	8.16e-05	0.000691	CcSEcCtD
Mefenamic acid—Mental disorder—Doxorubicin—stomach cancer	8.09e-05	0.000685	CcSEcCtD
Mefenamic acid—Urticaria—Capecitabine—stomach cancer	8.08e-05	0.000685	CcSEcCtD
Mefenamic acid—Ill-defined disorder—Epirubicin—stomach cancer	8.06e-05	0.000683	CcSEcCtD
Mefenamic acid—Body temperature increased—Capecitabine—stomach cancer	8.04e-05	0.000681	CcSEcCtD
Mefenamic acid—Abdominal pain—Capecitabine—stomach cancer	8.04e-05	0.000681	CcSEcCtD
Mefenamic acid—Convulsion—Methotrexate—stomach cancer	8.04e-05	0.000681	CcSEcCtD
Mefenamic acid—Anaemia—Epirubicin—stomach cancer	8.03e-05	0.00068	CcSEcCtD
Mefenamic acid—Salicylic acid—PTGS2—stomach cancer	7.93e-05	0.0174	CrCbGaD
Mefenamic acid—Flatulence—Doxorubicin—stomach cancer	7.92e-05	0.000671	CcSEcCtD
Mefenamic acid—Tension—Doxorubicin—stomach cancer	7.88e-05	0.000668	CcSEcCtD
Mefenamic acid—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	7.85e-05	0.000665	CcSEcCtD
Mefenamic acid—Malaise—Epirubicin—stomach cancer	7.83e-05	0.000663	CcSEcCtD
Mefenamic acid—Discomfort—Methotrexate—stomach cancer	7.8e-05	0.000661	CcSEcCtD
Mefenamic acid—Nervousness—Doxorubicin—stomach cancer	7.8e-05	0.000661	CcSEcCtD
Mefenamic acid—Vertigo—Epirubicin—stomach cancer	7.8e-05	0.000661	CcSEcCtD
Mefenamic acid—Syncope—Epirubicin—stomach cancer	7.79e-05	0.00066	CcSEcCtD
Mefenamic acid—Leukopenia—Epirubicin—stomach cancer	7.77e-05	0.000659	CcSEcCtD
Mefenamic acid—Palpitations—Epirubicin—stomach cancer	7.67e-05	0.00065	CcSEcCtD
Mefenamic acid—Confusional state—Methotrexate—stomach cancer	7.64e-05	0.000647	CcSEcCtD
Mefenamic acid—Loss of consciousness—Epirubicin—stomach cancer	7.63e-05	0.000647	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Methotrexate—stomach cancer	7.57e-05	0.000642	CcSEcCtD
Mefenamic acid—Vision blurred—Doxorubicin—stomach cancer	7.57e-05	0.000642	CcSEcCtD
Mefenamic acid—Asthenia—Docetaxel—stomach cancer	7.54e-05	0.000639	CcSEcCtD
Mefenamic acid—Convulsion—Epirubicin—stomach cancer	7.52e-05	0.000637	CcSEcCtD
Mefenamic acid—Infection—Methotrexate—stomach cancer	7.52e-05	0.000637	CcSEcCtD
Mefenamic acid—Hypertension—Epirubicin—stomach cancer	7.5e-05	0.000635	CcSEcCtD
Mefenamic acid—Ill-defined disorder—Doxorubicin—stomach cancer	7.45e-05	0.000632	CcSEcCtD
Mefenamic acid—Pruritus—Docetaxel—stomach cancer	7.43e-05	0.00063	CcSEcCtD
Mefenamic acid—Anaemia—Doxorubicin—stomach cancer	7.43e-05	0.000629	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Methotrexate—stomach cancer	7.41e-05	0.000628	CcSEcCtD
Mefenamic acid—Anxiety—Epirubicin—stomach cancer	7.37e-05	0.000624	CcSEcCtD
Mefenamic acid—Skin disorder—Methotrexate—stomach cancer	7.36e-05	0.000623	CcSEcCtD
Mefenamic acid—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	7.34e-05	0.000622	CcSEcCtD
Mefenamic acid—Discomfort—Epirubicin—stomach cancer	7.3e-05	0.000619	CcSEcCtD
Mefenamic acid—Asthenia—Capecitabine—stomach cancer	7.3e-05	0.000618	CcSEcCtD
Mefenamic acid—Malaise—Doxorubicin—stomach cancer	7.25e-05	0.000614	CcSEcCtD
Mefenamic acid—Dry mouth—Epirubicin—stomach cancer	7.23e-05	0.000613	CcSEcCtD
Mefenamic acid—Vertigo—Doxorubicin—stomach cancer	7.22e-05	0.000612	CcSEcCtD
Mefenamic acid—Anorexia—Methotrexate—stomach cancer	7.22e-05	0.000612	CcSEcCtD
Mefenamic acid—Syncope—Doxorubicin—stomach cancer	7.21e-05	0.00061	CcSEcCtD
Mefenamic acid—Pruritus—Capecitabine—stomach cancer	7.2e-05	0.00061	CcSEcCtD
Mefenamic acid—Leukopenia—Doxorubicin—stomach cancer	7.19e-05	0.000609	CcSEcCtD
Mefenamic acid—Diarrhoea—Docetaxel—stomach cancer	7.19e-05	0.000609	CcSEcCtD
Mefenamic acid—Confusional state—Epirubicin—stomach cancer	7.15e-05	0.000605	CcSEcCtD
Mefenamic acid—Diclofenac—PTGS2—stomach cancer	7.1e-05	0.0156	CrCbGaD
Mefenamic acid—Palpitations—Doxorubicin—stomach cancer	7.1e-05	0.000602	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Epirubicin—stomach cancer	7.09e-05	0.0006	CcSEcCtD
Mefenamic acid—Oedema—Epirubicin—stomach cancer	7.09e-05	0.0006	CcSEcCtD
Mefenamic acid—Hypotension—Methotrexate—stomach cancer	7.08e-05	0.0006	CcSEcCtD
Mefenamic acid—Salicylic acid—ALB—stomach cancer	7.07e-05	0.0155	CrCbGaD
Mefenamic acid—Loss of consciousness—Doxorubicin—stomach cancer	7.06e-05	0.000598	CcSEcCtD
Mefenamic acid—Infection—Epirubicin—stomach cancer	7.04e-05	0.000597	CcSEcCtD
Mefenamic acid—Shock—Epirubicin—stomach cancer	6.97e-05	0.000591	CcSEcCtD
Mefenamic acid—Convulsion—Doxorubicin—stomach cancer	6.96e-05	0.00059	CcSEcCtD
Mefenamic acid—Diarrhoea—Capecitabine—stomach cancer	6.96e-05	0.00059	CcSEcCtD
Mefenamic acid—Flurbiprofen—PTGS2—stomach cancer	6.95e-05	0.0153	CrCbGaD
Mefenamic acid—Dizziness—Docetaxel—stomach cancer	6.95e-05	0.000589	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Epirubicin—stomach cancer	6.94e-05	0.000588	CcSEcCtD
Mefenamic acid—Hypertension—Doxorubicin—stomach cancer	6.94e-05	0.000588	CcSEcCtD
Mefenamic acid—Tachycardia—Epirubicin—stomach cancer	6.92e-05	0.000586	CcSEcCtD
Mefenamic acid—Skin disorder—Epirubicin—stomach cancer	6.88e-05	0.000583	CcSEcCtD
Mefenamic acid—Insomnia—Methotrexate—stomach cancer	6.85e-05	0.00058	CcSEcCtD
Mefenamic acid—Anxiety—Doxorubicin—stomach cancer	6.82e-05	0.000578	CcSEcCtD
Mefenamic acid—Paraesthesia—Methotrexate—stomach cancer	6.8e-05	0.000576	CcSEcCtD
Mefenamic acid—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	6.79e-05	0.000576	CcSEcCtD
Mefenamic acid—Discomfort—Doxorubicin—stomach cancer	6.76e-05	0.000573	CcSEcCtD
Mefenamic acid—Anorexia—Epirubicin—stomach cancer	6.76e-05	0.000572	CcSEcCtD
Mefenamic acid—Dyspnoea—Methotrexate—stomach cancer	6.75e-05	0.000572	CcSEcCtD
Mefenamic acid—Somnolence—Methotrexate—stomach cancer	6.73e-05	0.00057	CcSEcCtD
Mefenamic acid—Dizziness—Capecitabine—stomach cancer	6.73e-05	0.00057	CcSEcCtD
Mefenamic acid—Dry mouth—Doxorubicin—stomach cancer	6.69e-05	0.000567	CcSEcCtD
Mefenamic acid—Vomiting—Docetaxel—stomach cancer	6.68e-05	0.000566	CcSEcCtD
Mefenamic acid—Dyspepsia—Methotrexate—stomach cancer	6.67e-05	0.000565	CcSEcCtD
Mefenamic acid—Rash—Docetaxel—stomach cancer	6.62e-05	0.000561	CcSEcCtD
Mefenamic acid—Hypotension—Epirubicin—stomach cancer	6.62e-05	0.000561	CcSEcCtD
Mefenamic acid—Dermatitis—Docetaxel—stomach cancer	6.62e-05	0.000561	CcSEcCtD
Mefenamic acid—Confusional state—Doxorubicin—stomach cancer	6.61e-05	0.00056	CcSEcCtD
Mefenamic acid—Decreased appetite—Methotrexate—stomach cancer	6.58e-05	0.000558	CcSEcCtD
Mefenamic acid—Headache—Docetaxel—stomach cancer	6.58e-05	0.000558	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Doxorubicin—stomach cancer	6.56e-05	0.000556	CcSEcCtD
Mefenamic acid—Oedema—Doxorubicin—stomach cancer	6.56e-05	0.000556	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Methotrexate—stomach cancer	6.54e-05	0.000554	CcSEcCtD
Mefenamic acid—Infection—Doxorubicin—stomach cancer	6.51e-05	0.000552	CcSEcCtD
Mefenamic acid—Vomiting—Capecitabine—stomach cancer	6.47e-05	0.000548	CcSEcCtD
Mefenamic acid—Shock—Doxorubicin—stomach cancer	6.45e-05	0.000547	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Doxorubicin—stomach cancer	6.42e-05	0.000544	CcSEcCtD
Mefenamic acid—Rash—Capecitabine—stomach cancer	6.41e-05	0.000543	CcSEcCtD
Mefenamic acid—Insomnia—Epirubicin—stomach cancer	6.41e-05	0.000543	CcSEcCtD
Mefenamic acid—Dermatitis—Capecitabine—stomach cancer	6.41e-05	0.000543	CcSEcCtD
Mefenamic acid—Tachycardia—Doxorubicin—stomach cancer	6.4e-05	0.000542	CcSEcCtD
Mefenamic acid—Headache—Capecitabine—stomach cancer	6.37e-05	0.00054	CcSEcCtD
Mefenamic acid—Skin disorder—Doxorubicin—stomach cancer	6.37e-05	0.00054	CcSEcCtD
Mefenamic acid—Paraesthesia—Epirubicin—stomach cancer	6.36e-05	0.000539	CcSEcCtD
Mefenamic acid—Diclofenac—ALB—stomach cancer	6.33e-05	0.0139	CrCbGaD
Mefenamic acid—Dyspnoea—Epirubicin—stomach cancer	6.32e-05	0.000535	CcSEcCtD
Mefenamic acid—Somnolence—Epirubicin—stomach cancer	6.3e-05	0.000534	CcSEcCtD
Mefenamic acid—Ketoprofen—PTGS2—stomach cancer	6.29e-05	0.0138	CrCbGaD
Mefenamic acid—Anorexia—Doxorubicin—stomach cancer	6.25e-05	0.00053	CcSEcCtD
Mefenamic acid—Nausea—Docetaxel—stomach cancer	6.24e-05	0.000529	CcSEcCtD
Mefenamic acid—Feeling abnormal—Methotrexate—stomach cancer	6.24e-05	0.000529	CcSEcCtD
Mefenamic acid—Dyspepsia—Epirubicin—stomach cancer	6.24e-05	0.000529	CcSEcCtD
Mefenamic acid—Flurbiprofen—ALB—stomach cancer	6.2e-05	0.0136	CrCbGaD
Mefenamic acid—Gastrointestinal pain—Methotrexate—stomach cancer	6.19e-05	0.000525	CcSEcCtD
Mefenamic acid—Decreased appetite—Epirubicin—stomach cancer	6.16e-05	0.000522	CcSEcCtD
Mefenamic acid—Hypotension—Doxorubicin—stomach cancer	6.13e-05	0.000519	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Epirubicin—stomach cancer	6.12e-05	0.000518	CcSEcCtD
Mefenamic acid—Constipation—Epirubicin—stomach cancer	6.06e-05	0.000513	CcSEcCtD
Mefenamic acid—Nausea—Capecitabine—stomach cancer	6.04e-05	0.000512	CcSEcCtD
Mefenamic acid—Urticaria—Methotrexate—stomach cancer	6.02e-05	0.00051	CcSEcCtD
Mefenamic acid—Abdominal pain—Methotrexate—stomach cancer	5.99e-05	0.000507	CcSEcCtD
Mefenamic acid—Body temperature increased—Methotrexate—stomach cancer	5.99e-05	0.000507	CcSEcCtD
Mefenamic acid—Insomnia—Doxorubicin—stomach cancer	5.93e-05	0.000502	CcSEcCtD
Mefenamic acid—Paraesthesia—Doxorubicin—stomach cancer	5.89e-05	0.000499	CcSEcCtD
Mefenamic acid—Dyspnoea—Doxorubicin—stomach cancer	5.85e-05	0.000495	CcSEcCtD
Mefenamic acid—Feeling abnormal—Epirubicin—stomach cancer	5.84e-05	0.000495	CcSEcCtD
Mefenamic acid—Somnolence—Doxorubicin—stomach cancer	5.83e-05	0.000494	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Epirubicin—stomach cancer	5.8e-05	0.000491	CcSEcCtD
Mefenamic acid—Dyspepsia—Doxorubicin—stomach cancer	5.77e-05	0.000489	CcSEcCtD
Mefenamic acid—Decreased appetite—Doxorubicin—stomach cancer	5.7e-05	0.000483	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Doxorubicin—stomach cancer	5.66e-05	0.00048	CcSEcCtD
Mefenamic acid—Urticaria—Epirubicin—stomach cancer	5.63e-05	0.000477	CcSEcCtD
Mefenamic acid—Constipation—Doxorubicin—stomach cancer	5.61e-05	0.000475	CcSEcCtD
Mefenamic acid—Ketoprofen—ALB—stomach cancer	5.61e-05	0.0123	CrCbGaD
Mefenamic acid—Body temperature increased—Epirubicin—stomach cancer	5.6e-05	0.000475	CcSEcCtD
Mefenamic acid—Abdominal pain—Epirubicin—stomach cancer	5.6e-05	0.000475	CcSEcCtD
Mefenamic acid—Asthenia—Methotrexate—stomach cancer	5.43e-05	0.00046	CcSEcCtD
Mefenamic acid—Feeling abnormal—Doxorubicin—stomach cancer	5.4e-05	0.000458	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Doxorubicin—stomach cancer	5.36e-05	0.000454	CcSEcCtD
Mefenamic acid—Pruritus—Methotrexate—stomach cancer	5.36e-05	0.000454	CcSEcCtD
Mefenamic acid—Urticaria—Doxorubicin—stomach cancer	5.21e-05	0.000441	CcSEcCtD
Mefenamic acid—Abdominal pain—Doxorubicin—stomach cancer	5.18e-05	0.000439	CcSEcCtD
Mefenamic acid—Body temperature increased—Doxorubicin—stomach cancer	5.18e-05	0.000439	CcSEcCtD
Mefenamic acid—Diarrhoea—Methotrexate—stomach cancer	5.18e-05	0.000439	CcSEcCtD
Mefenamic acid—Asthenia—Epirubicin—stomach cancer	5.08e-05	0.000431	CcSEcCtD
Mefenamic acid—Pruritus—Epirubicin—stomach cancer	5.01e-05	0.000425	CcSEcCtD
Mefenamic acid—Dizziness—Methotrexate—stomach cancer	5.01e-05	0.000424	CcSEcCtD
Mefenamic acid—Diarrhoea—Epirubicin—stomach cancer	4.85e-05	0.000411	CcSEcCtD
Mefenamic acid—Vomiting—Methotrexate—stomach cancer	4.81e-05	0.000408	CcSEcCtD
Mefenamic acid—Rash—Methotrexate—stomach cancer	4.77e-05	0.000405	CcSEcCtD
Mefenamic acid—Dermatitis—Methotrexate—stomach cancer	4.77e-05	0.000404	CcSEcCtD
Mefenamic acid—Headache—Methotrexate—stomach cancer	4.74e-05	0.000402	CcSEcCtD
Mefenamic acid—Asthenia—Doxorubicin—stomach cancer	4.7e-05	0.000399	CcSEcCtD
Mefenamic acid—Dizziness—Epirubicin—stomach cancer	4.69e-05	0.000397	CcSEcCtD
Mefenamic acid—Pruritus—Doxorubicin—stomach cancer	4.64e-05	0.000393	CcSEcCtD
Mefenamic acid—Vomiting—Epirubicin—stomach cancer	4.51e-05	0.000382	CcSEcCtD
Mefenamic acid—Nausea—Methotrexate—stomach cancer	4.5e-05	0.000381	CcSEcCtD
Mefenamic acid—Diarrhoea—Doxorubicin—stomach cancer	4.49e-05	0.00038	CcSEcCtD
Mefenamic acid—Rash—Epirubicin—stomach cancer	4.47e-05	0.000379	CcSEcCtD
Mefenamic acid—Dermatitis—Epirubicin—stomach cancer	4.46e-05	0.000378	CcSEcCtD
Mefenamic acid—Headache—Epirubicin—stomach cancer	4.44e-05	0.000376	CcSEcCtD
Mefenamic acid—Dizziness—Doxorubicin—stomach cancer	4.34e-05	0.000367	CcSEcCtD
Mefenamic acid—Nausea—Epirubicin—stomach cancer	4.21e-05	0.000357	CcSEcCtD
Mefenamic acid—Vomiting—Doxorubicin—stomach cancer	4.17e-05	0.000353	CcSEcCtD
Mefenamic acid—Rash—Doxorubicin—stomach cancer	4.13e-05	0.00035	CcSEcCtD
Mefenamic acid—Dermatitis—Doxorubicin—stomach cancer	4.13e-05	0.00035	CcSEcCtD
Mefenamic acid—Headache—Doxorubicin—stomach cancer	4.11e-05	0.000348	CcSEcCtD
Mefenamic acid—Nausea—Doxorubicin—stomach cancer	3.89e-05	0.00033	CcSEcCtD
Mefenamic acid—PTGS2—Disease—RBP4—stomach cancer	1.43e-05	0.000178	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—RHOA—stomach cancer	1.43e-05	0.000177	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	1.43e-05	0.000177	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	1.43e-05	0.000177	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—NOS3—stomach cancer	1.42e-05	0.000176	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—RPS26—stomach cancer	1.41e-05	0.000175	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—PPIA—stomach cancer	1.4e-05	0.000173	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—MYC—stomach cancer	1.4e-05	0.000173	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—SREBF2—stomach cancer	1.4e-05	0.000173	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—UMPS—stomach cancer	1.39e-05	0.000172	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CKB—stomach cancer	1.39e-05	0.000172	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CA1—stomach cancer	1.39e-05	0.000172	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—NDUFA2—stomach cancer	1.39e-05	0.000172	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—FBP1—stomach cancer	1.39e-05	0.000172	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—PPARG—stomach cancer	1.38e-05	0.000171	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—ERBB2—stomach cancer	1.38e-05	0.000171	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—RORA—stomach cancer	1.38e-05	0.000171	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—MAPK1—stomach cancer	1.37e-05	0.000169	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—EGFR—stomach cancer	1.37e-05	0.000169	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	1.36e-05	0.000169	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—IRS2—stomach cancer	1.35e-05	0.000168	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—PIK3CA—stomach cancer	1.35e-05	0.000168	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	1.35e-05	0.000167	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	1.35e-05	0.000167	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—ERBB2—stomach cancer	1.33e-05	0.000164	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—GSTT1—stomach cancer	1.32e-05	0.000163	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CAV1—stomach cancer	1.31e-05	0.000163	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—APOA1—stomach cancer	1.31e-05	0.000162	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—CXCL8—stomach cancer	1.31e-05	0.000162	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PLIN2—stomach cancer	1.3e-05	0.000161	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—CYP2A6—stomach cancer	1.3e-05	0.000161	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—PTGS2—stomach cancer	1.3e-05	0.000161	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—ALDOB—stomach cancer	1.29e-05	0.00016	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—KRAS—stomach cancer	1.29e-05	0.00016	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PDHA1—stomach cancer	1.29e-05	0.00016	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—ECHS1—stomach cancer	1.29e-05	0.00016	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—CDKN1B—stomach cancer	1.28e-05	0.000158	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CA2—stomach cancer	1.27e-05	0.000157	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—AKR1C3—stomach cancer	1.27e-05	0.000157	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—PRKCB—stomach cancer	1.25e-05	0.000155	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—IL6ST—stomach cancer	1.25e-05	0.000154	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	1.24e-05	0.000154	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—ALB—stomach cancer	1.24e-05	0.000154	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PGAM1—stomach cancer	1.23e-05	0.000153	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—NT5E—stomach cancer	1.23e-05	0.000153	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—ENO1—stomach cancer	1.23e-05	0.000153	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—CDKN1B—stomach cancer	1.23e-05	0.000152	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—CCND1—stomach cancer	1.22e-05	0.000151	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	1.22e-05	0.000151	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—JUN—stomach cancer	1.22e-05	0.000151	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	1.22e-05	0.000151	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—ALB—stomach cancer	1.21e-05	0.00015	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—FADS1—stomach cancer	1.21e-05	0.00015	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—TYMP—stomach cancer	1.21e-05	0.00015	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—ALOX5—stomach cancer	1.2e-05	0.000149	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	1.2e-05	0.000149	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—RPS19—stomach cancer	1.2e-05	0.000149	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—AKR1C3—stomach cancer	1.2e-05	0.000149	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—APC—stomach cancer	1.2e-05	0.000148	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—NOS3—stomach cancer	1.19e-05	0.000147	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—PIK3CA—stomach cancer	1.19e-05	0.000147	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—MMP9—stomach cancer	1.18e-05	0.000147	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—DPYD—stomach cancer	1.18e-05	0.000146	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—CDKN1A—stomach cancer	1.18e-05	0.000146	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—ALDH7A1—stomach cancer	1.18e-05	0.000146	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PLCE1—stomach cancer	1.18e-05	0.000146	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—ENO1—stomach cancer	1.17e-05	0.000145	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—MAPK8—stomach cancer	1.15e-05	0.000143	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—SREBF2—stomach cancer	1.14e-05	0.000141	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—CDKN1A—stomach cancer	1.13e-05	0.00014	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—UMPS—stomach cancer	1.13e-05	0.00014	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—RORA—stomach cancer	1.12e-05	0.000139	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—IL6R—stomach cancer	1.11e-05	0.000138	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—HRAS—stomach cancer	1.1e-05	0.000136	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—CD44—stomach cancer	1.09e-05	0.000136	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—PTGS2—stomach cancer	1.09e-05	0.000135	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	1.07e-05	0.000133	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—VEGFA—stomach cancer	1.06e-05	0.000132	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	1.06e-05	0.000132	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—RPS6—stomach cancer	1.06e-05	0.000131	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—STAT3—stomach cancer	1.05e-05	0.00013	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—ALDOB—stomach cancer	1.05e-05	0.00013	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—IL6—stomach cancer	1.05e-05	0.00013	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PDHA1—stomach cancer	1.05e-05	0.00013	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—ECHS1—stomach cancer	1.05e-05	0.00013	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—GSTT1—stomach cancer	1.05e-05	0.000129	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—SERPINE1—stomach cancer	1.04e-05	0.000129	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—CD44—stomach cancer	1.04e-05	0.000128	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—CYP2A6—stomach cancer	1.03e-05	0.000128	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—STAT3—stomach cancer	1.01e-05	0.000125	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—MAPK3—stomach cancer	1.01e-05	0.000125	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—AKR1C3—stomach cancer	1.01e-05	0.000124	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—RHOA—stomach cancer	1e-05	0.000124	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—PIK3CA—stomach cancer	9.93e-06	0.000123	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—NOS3—stomach cancer	9.93e-06	0.000123	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	9.92e-06	0.000123	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	9.89e-06	0.000123	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—FADS1—stomach cancer	9.87e-06	0.000122	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—TYMP—stomach cancer	9.87e-06	0.000122	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—ENO1—stomach cancer	9.8e-06	0.000121	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—MYC—stomach cancer	9.78e-06	0.000121	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—ALOX5—stomach cancer	9.78e-06	0.000121	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—HBEGF—stomach cancer	9.75e-06	0.000121	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—MAPK3—stomach cancer	9.67e-06	0.00012	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—ALB—stomach cancer	9.63e-06	0.000119	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—DPYD—stomach cancer	9.62e-06	0.000119	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—MAPK1—stomach cancer	9.57e-06	0.000119	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—EGFR—stomach cancer	9.57e-06	0.000119	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—MYC—stomach cancer	9.4e-06	0.000116	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PPP2R1A—stomach cancer	9.31e-06	0.000115	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—ERBB2—stomach cancer	9.29e-06	0.000115	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—SREBF2—stomach cancer	9.24e-06	0.000114	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—MAPK1—stomach cancer	9.2e-06	0.000114	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—EGFR—stomach cancer	9.2e-06	0.000114	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—RORA—stomach cancer	9.13e-06	0.000113	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—GSTP1—stomach cancer	9.13e-06	0.000113	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—KRAS—stomach cancer	9.04e-06	0.000112	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—HMOX1—stomach cancer	9e-06	0.000111	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—PPP2R1A—stomach cancer	8.82e-06	0.000109	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CXCL8—stomach cancer	8.81e-06	0.000109	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	8.72e-06	0.000108	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—CD44—stomach cancer	8.69e-06	0.000108	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—KRAS—stomach cancer	8.69e-06	0.000108	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CDKN1B—stomach cancer	8.6e-06	0.000107	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—ALDOB—stomach cancer	8.56e-06	0.000106	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—GSTT1—stomach cancer	8.51e-06	0.000105	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—TYMS—stomach cancer	8.49e-06	0.000105	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CYP2A6—stomach cancer	8.41e-06	0.000104	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—GSTM1—stomach cancer	8.39e-06	0.000104	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—PIK3CA—stomach cancer	8.31e-06	0.000103	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CCND1—stomach cancer	8.21e-06	0.000102	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—JUN—stomach cancer	8.19e-06	0.000101	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—SMAD4—stomach cancer	8.19e-06	0.000101	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—AKR1C3—stomach cancer	8.18e-06	0.000101	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	8.07e-06	0.0001	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	8.05e-06	9.97e-05	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—TP53—stomach cancer	8.03e-06	9.95e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—PIK3CA—stomach cancer	7.98e-06	9.88e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—ENO1—stomach cancer	7.97e-06	9.87e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—MMP9—stomach cancer	7.97e-06	9.87e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—ALOX5—stomach cancer	7.96e-06	9.86e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CDKN1A—stomach cancer	7.94e-06	9.83e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—ERCC2—stomach cancer	7.89e-06	9.77e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—ALB—stomach cancer	7.84e-06	9.71e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—DPYD—stomach cancer	7.83e-06	9.7e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—FYN—stomach cancer	7.78e-06	9.63e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—MAPK8—stomach cancer	7.75e-06	9.6e-05	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—HRAS—stomach cancer	7.68e-06	9.52e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—ERCC2—stomach cancer	7.48e-06	9.26e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—MTHFR—stomach cancer	7.41e-06	9.18e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—PPP2R1A—stomach cancer	7.39e-06	9.15e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—HRAS—stomach cancer	7.38e-06	9.14e-05	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—IL6—stomach cancer	7.35e-06	9.11e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—FGFR2—stomach cancer	7.3e-06	9.04e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—GSTP1—stomach cancer	7.25e-06	8.97e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—VEGFA—stomach cancer	7.16e-06	8.86e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—HMOX1—stomach cancer	7.15e-06	8.85e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	7.1e-06	8.79e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—STAT3—stomach cancer	7.09e-06	8.77e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CD44—stomach cancer	7.07e-06	8.76e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—IL6—stomach cancer	7.07e-06	8.75e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—MTHFR—stomach cancer	7.03e-06	8.7e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—GSTT1—stomach cancer	6.92e-06	8.57e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	6.86e-06	8.49e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CYP2A6—stomach cancer	6.84e-06	8.48e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—CAV1—stomach cancer	6.84e-06	8.47e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—APOA1—stomach cancer	6.82e-06	8.45e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—MAPK3—stomach cancer	6.77e-06	8.38e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—TYMS—stomach cancer	6.74e-06	8.34e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—IRS2—stomach cancer	6.68e-06	8.28e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—PIK3CA—stomach cancer	6.68e-06	8.28e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—GSTM1—stomach cancer	6.66e-06	8.25e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—AKR1C3—stomach cancer	6.66e-06	8.24e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—MYC—stomach cancer	6.58e-06	8.15e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	6.53e-06	8.09e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—ENO1—stomach cancer	6.49e-06	8.03e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—CAV1—stomach cancer	6.48e-06	8.03e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—APOA1—stomach cancer	6.47e-06	8.01e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—MAPK1—stomach cancer	6.44e-06	7.98e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—EGFR—stomach cancer	6.44e-06	7.98e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—ALB—stomach cancer	6.38e-06	7.9e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—ERCC2—stomach cancer	6.26e-06	7.75e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—IL6ST—stomach cancer	6.14e-06	7.61e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—KRAS—stomach cancer	6.08e-06	7.53e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PPARG—stomach cancer	6.01e-06	7.44e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PPP2R1A—stomach cancer	6.01e-06	7.44e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—APC—stomach cancer	5.9e-06	7.31e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—GSTP1—stomach cancer	5.9e-06	7.3e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—MTHFR—stomach cancer	5.88e-06	7.29e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—HMOX1—stomach cancer	5.81e-06	7.2e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CD44—stomach cancer	5.75e-06	7.13e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—PIK3CA—stomach cancer	5.59e-06	6.92e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	5.58e-06	6.91e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—IL6R—stomach cancer	5.48e-06	6.79e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—TYMS—stomach cancer	5.48e-06	6.79e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—CAV1—stomach cancer	5.43e-06	6.72e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—GSTM1—stomach cancer	5.42e-06	6.71e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—APOA1—stomach cancer	5.42e-06	6.71e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—TP53—stomach cancer	5.41e-06	6.7e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—ALB—stomach cancer	5.41e-06	6.69e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	5.19e-06	6.42e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—HRAS—stomach cancer	5.17e-06	6.4e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—NOS3—stomach cancer	5.17e-06	6.4e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—SERPINE1—stomach cancer	5.13e-06	6.36e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—ERCC2—stomach cancer	5.09e-06	6.31e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—RHOA—stomach cancer	4.95e-06	6.13e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—IL6—stomach cancer	4.95e-06	6.13e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—NOS3—stomach cancer	4.9e-06	6.07e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PPP2R1A—stomach cancer	4.89e-06	6.06e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—GSTP1—stomach cancer	4.8e-06	5.94e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—MTHFR—stomach cancer	4.79e-06	5.93e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—PPARG—stomach cancer	4.77e-06	5.91e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—HMOX1—stomach cancer	4.73e-06	5.86e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PTGS2—stomach cancer	4.73e-06	5.86e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—ERBB2—stomach cancer	4.58e-06	5.68e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—TYMS—stomach cancer	4.46e-06	5.52e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CAV1—stomach cancer	4.42e-06	5.47e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—GSTM1—stomach cancer	4.41e-06	5.46e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—APOA1—stomach cancer	4.41e-06	5.46e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—ALB—stomach cancer	4.29e-06	5.31e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—CDKN1B—stomach cancer	4.25e-06	5.26e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	4.22e-06	5.23e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—ERCC2—stomach cancer	4.15e-06	5.13e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—NOS3—stomach cancer	4.1e-06	5.08e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—CDKN1A—stomach cancer	3.92e-06	4.85e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—MTHFR—stomach cancer	3.9e-06	4.83e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PPARG—stomach cancer	3.88e-06	4.81e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CAV1—stomach cancer	3.59e-06	4.45e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—APOA1—stomach cancer	3.59e-06	4.44e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—STAT3—stomach cancer	3.5e-06	4.33e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—ALB—stomach cancer	3.49e-06	4.32e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	3.43e-06	4.25e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—MAPK3—stomach cancer	3.34e-06	4.14e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—NOS3—stomach cancer	3.34e-06	4.14e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—MYC—stomach cancer	3.25e-06	4.02e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—MAPK1—stomach cancer	3.18e-06	3.94e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—EGFR—stomach cancer	3.18e-06	3.94e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PPARG—stomach cancer	3.16e-06	3.91e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PTGS2—stomach cancer	3.05e-06	3.78e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—KRAS—stomach cancer	3e-06	3.72e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PIK3CA—stomach cancer	2.91e-06	3.6e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—ALB—stomach cancer	2.84e-06	3.52e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—PIK3CA—stomach cancer	2.76e-06	3.42e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—NOS3—stomach cancer	2.72e-06	3.37e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—HRAS—stomach cancer	2.55e-06	3.16e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PTGS2—stomach cancer	2.49e-06	3.08e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—IL6—stomach cancer	2.44e-06	3.02e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—PIK3CA—stomach cancer	2.31e-06	2.86e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PIK3CA—stomach cancer	1.88e-06	2.33e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PIK3CA—stomach cancer	1.53e-06	1.89e-05	CbGpPWpGaD
